http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-950013371-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N57-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-653
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N55-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N57-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-653
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N55-00
filingDate 1994-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1995-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-950013371-A
titleOfInvention Use of phosphoric esters as crystallisation inhibitors
abstract The invention relates to the application of A) certain azole derivatives with crystallization tendencies and B), if appropriate, spraying aqueous mixtures containing one or more other glidants and additives, in the spraying apparatus of active compounds having a tendency to crystallize. It relates to a phosphate ester of the general formula (1) which can be used to prevent crystallization.n n n n n n n n In the formula, R 1 represents alkyl having 2 to 18 carbon atoms, and R 2 and R 3 independently represent alkyl having 2 to 12 carbon atoms.
priorityDate 1993-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394669
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411738766
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393732
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393640
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393736
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456094451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393713
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394678
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393739

Total number of triples: 38.